Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL356545

O=C(O)C(F)(F)F.OCCNCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGIRfolP

The experimentally established mechanism targets of Trifluoroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA3 P07451 2/20 0.41
CA5A P35218 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
CA2 P00918 2/20 0.41
CA12 O43570 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ALDH1A1 P00352 6/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
POLB P06746 2/20 0.37
HTT P42858 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HDAC6 Q9UBN7 1/20 0.35
LMNA P02545 3/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethanolamine SCHEMBL1832177 0.83 THRB (0.39) CA3CA5ACA5BCA2CA12
Trifluoroacetic Acid SCHEMBL3399564 0.82 ALDH1A1 (0.41) CA3CA5ACA5BCA2CA12
Trifluoroacetic Acid SCHEMBL1832229 0.80 ALDH1A1 (0.36) CA3CA5ACA5BCA2CA12
Diethanolamine SCHEMBL1833343 0.80 KDM4E (0.39) CA2CA9ALDH1A1SMN1; SMN2POLB
Trifluoroacetic Acid SCHEMBL11404300 0.80 ALDH1A1 (0.36) CA2ALDH1A1SMN1; SMN2POLBMEN1
Diethanolamine SCHEMBL1832822 0.80 KDM4E (0.39) CA2CA9ALDH1A1SMN1; SMN2POLB
Trifluoroacetic Acid SCHEMBL11509703 0.80 ALDH1A1 (0.36) CA2ALDH1A1SMN1; SMN2POLBMEN1
Diethanolamine SCHEMBL1839514 0.80 THRB (0.52) CA3CA5ACA5BCA2CA12
Trichloroacetic Acid SCHEMBL5874381 0.79 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBHTTMEN1
Diethanolamine SCHEMBL1401642 0.77 KDM4E (0.47) ALDH1A1SMN1; SMN2POLBHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260088410-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS HENKEL AG & CO KGAA (DE) 2026-03-26 US claimed
WO-2025119658-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-06-12 WO claimed
EP-4567085-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM Henkel AG & Co. KGaA (DE) 2025-06-11 EP claimed
WO-2024260662-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS HENKEL AG & CO. KGAA (DE) 2024-12-26 WO claimed
EP-4481913-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS Henkel AG & Co. KGaA (DE) 2024-12-25 EP claimed
CN-114787314-B Two-component (2K) curable adhesive composition 汉高股份有限及两合公司 2024-11-29 CN claimed
CN-114787305-B Two-component (2K) curable adhesive composition 汉高股份有限及两合公司 2024-09-03 CN claimed
US-20240191108-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION HENKEL AG & CO KGAA (DE) 2024-06-13 US claimed
US-20240067850-A1 DEBONDABLE STRUCTURE BASED ON A SOLVENT-BORNE PRESSURE SENSITIVE ADHESIVE (PSA) HENKEL AG & CO KGAA (DE) 2024-02-29 US claimed
EP-4323463-A1 DEBONDABLE STRUCTURE BASED ON A SOLVENT-BORNE PRESSURE SENSITIVE ADHESIVE (PSA) Henkel AG & Co. KGaA (DE) 2024-02-21 EP claimed
EP-3835386-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2021-06-16 EP claimed
EP-3835378-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2021-06-16 EP claimed
EP-2776819-B1 ELECTROCHEMICAL GAS SENSOR WITH AN IONIC LIQUID AS ELECTROLYTE FOR THE DETECTION OF AMMONIA AND AMINES MSA EUROPE GMBH (CH) 2018-12-19 EP claimed
US-20140299470-A1 ELECTROCHEMICAL GAS SENSOR WITH AN IONIC LIQUID AS ELECTROLYTE FOR THE DETECTION OF AMMONIA AND AMINES MSA AUER GMBH (DE) 2014-10-09 US claimed
EP-2414476-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. du Pont de Nemours and Company (US) 2012-02-08 EP claimed
US-20120011886-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY 2012-01-19 US claimed
WO-2010117836-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-14 WO claimed
US-20070185330-A1 Liquids THE UNIVERSITY OF YORK (GB) 2007-08-09 US claimed
EP-1805131-A2 IONIC LIQUIDS COMPRISING NITROGEN CONTAINING CATIONS THE UNIVERSITY OF YORK (GB) 2007-07-11 EP claimed
WO-2005097731-A2 IONIC LIQUIDS COMPRISING NITROGEN CONTAINING CATIONS THE UNIVERSITY OF YORK (GB) 2005-10-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088410-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS EPCAM, CDH1, ITGA4 CA3 944/4885CA5A 2990/4885CA5B 1873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.